Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for multiple hereditary hypercoagulability factors using the amplification refractory mutation system.

Berthold Hoppe1, Guido A Heymann, Jürgen Koscielny

  • 1Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin Campus Virchow-Klinikum, Humboldt-Universität Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. berthold.hoppe@charite.de

Thrombosis Research
|December 4, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microsurgical Evacuation Efficacy and Functional Outcomes in Spontaneous Intracerebral Hemorrhage by Type of Antithrombotic Therapy.

Neurosurgery·2026
Same author

Hamostaseologie·2026
Same author

Hamostaseologie·2026
Same author

Detection of Liver Dysfunction in Severe Burn Injury with Bedside Measurement of Perfusion.

Medicina (Kaunas, Lithuania)·2026
Same author

[Digitalisierung im Gesundheitswesen - eine kritische Bestandsaufnahme].

Hamostaseologie·2026
Same author

Longitudinal metabolomics study of phosphate-adenine-guanosine-glucose-saline-mannitol stored red blood cells.

Transfusion·2026
Same journal

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Thrombosis research·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
See all related articles

This study introduces a new Amplification Refractory Mutation System (ARMS) method. It simplifies screening for multiple hereditary hypercoagulability risk factors simultaneously under uniform PCR conditions.

Area of Science:

  • Genetics and Molecular Biology
  • Thrombosis Research
  • Medical Diagnostics

Background:

  • Hereditary factors significantly contribute to arterial and venous thromboembolic diseases.
  • Existing Amplification Refractory Mutation System (ARMS) methods for identifying these risk factors are technically variable.
  • This variability complicates the screening process for hypercoagulability.

Purpose of the Study:

  • To develop a novel, streamlined Amplification Refractory Mutation System (ARMS) based approach.
  • To enable simultaneous screening for multiple hereditary hypercoagulability factors.
  • To standardize the technical conditions for ARMS analysis.

Main Methods:

  • Development of a novel Amplification Refractory Mutation System (ARMS) assay.

Related Experiment Videos

  • Implementation of identical Polymerase Chain Reaction (PCR) conditions for multiple targets.
  • Simultaneous analysis of various hypercoagulability factors.

    • Main Results:

    • Successfully developed a novel ARMS-based system for multiplex screening.
    • Achieved simultaneous detection of multiple hypercoagulability factors.
    • Established identical PCR conditions applicable to all analyzed factors, simplifying the workflow.

    Conclusions:

    • The novel ARMS system significantly simplifies the screening process for hereditary hypercoagulability.
    • This standardized approach reduces technical variability in genetic risk factor analysis.
    • Facilitates more efficient and accessible diagnosis of inherited thrombophilia.